FDA 483 - Abbott Laboratories - April 01, 2009

Abbott Nutrition in Columbus, OH was inspected regarding its infant formula manufacturing. The inspection revealed significant deficiencies in the firm's complaint handling procedures and its actual investigation of infant formula complaints, particularly concerning potential health hazards to infants. These issues indicate a failure to adequately investigate serious complaints involving multiple infants experiencing adverse symptoms.